Please note: The information displayed on this page might be outdated.
Evofem Biosciences, Inc.: Evofem Biosciences (EVFM) is developing Amphora®, a Multipurpose Vaginal pH Regulator (MVP-R) and non-hormonal, on-demand, woman-controlled vaginal gel for birth control and the prevention of urogenital acquisition of certain STIs. In December 2018, the Company reported positive top-line data from its confirmatory Phase 3 study in ~1400 women in the US; submitted NDA for Amphora in Nov 2019, PDUFA of 5.25.20 with a potential US launch in 2020. Dec 2019 announced positive topline results of Ph 2b trial of Amphora for the prevention of chlamydia and gonorrhea.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - Pacific
Clinical Stage
Phase III
Disease Space
Men's Health, Women's Health
Industry
Biotechnology
Listing
Public, USA
Market Cap
100MM - 500MM
Website:
Address:
12400 High Bluff Drive
Suite 600
San Diego, CA 92130
United States

Company Participants at Solebury Trout Management Access SF 2020

  • Amy Raskopf, Investor Relations
  • Cara Miller, VP, Corporate Communications & Public Relations
  • Jay File, Chief Financial Officer
  • Kelly Culwell, Chief Medical Officer
  • Russ Barrans, Chief Commercial Officer
  • Saundra Pelletier, CEO
  • Thomas Lynch, Chairman of the Board

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of Evofem Biosciences Inc Warrant 2018-22.05.25 on Evofem Bioscienc

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Bessemer Investment Management LLC 0.00 0 0.00 13F 6/30/20
Taylor Wealth Management Partners LLC 0.00 0 0.00 13F 6/30/20

Top 10 Holders of Evofem Biosciences, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Invesco Asset Management Ltd. 27.19 12,670,052 30.79 13F 6/30/20
Schroder Investment Management Ltd. 4.11 3,341,504 8.12 Funds 12/31/19
Schroder Investment Management International Ltd. 5.70 2,657,123 6.46 13F 6/30/20
Morgan Stanley & Co. LLC 5.40 2,514,498 6.11 13F 6/30/20
Vanguard Group, Inc. (Subfiler) 5.24 2,443,594 5.94 13F 6/30/20
The Vanguard Group, Inc. 5.21 2,430,896 5.91 Funds 8/31/20
Marshall Wace LLP 5.06 2,358,184 5.73 13F 6/30/20
Millennium Management LLC 3.82 1,778,516 4.32 13F 6/30/20
Heartland Advisors, Inc. 3.22 1,500,000 3.65 13F 6/30/20
BlackRock Fund Advisors 3.22 1,498,881 3.64 13F 6/30/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.